LBX2-AS1 as a Novel Diagnostic Biomarker and Therapeutic Target Facilitates Multiple Myeloma Progression by Enhancing mRNA Stability of LBX2.

导出 LinkOut

翻译打印收藏纠错

第一作者： Haipeng,Jia

第一单位： Department of Hematology, The Second Affiliated Hospital of Shandong First Medical University, Tai'an, China.

作者： Haipeng,Jia ^[1] ; Yan,Liu ^[1] ; Sulong,Lv ^[1] ; Ruifang,Qiao ^[2] ; Xiaofen,Zhang ^[1] ; Fei,Niu ^[3] ; Wenqing,Shang ^[1] ; Shumei,Liu ^[1] ; Jing,Dong ^[1] ; Zhirong,Zhang ^[1]

作者单位： Department of Hematology, The Second Affiliated Hospital of Shandong First Medical University, Tai'an, China. ^[1] Respiratory Intensive Care Unit, Tai'an City Central Hospital, Tai'an, China. ^[2] Department of Emergency, The Second Affiliated Hospital of Shandong First Medical University, Tai'an, China. ^[3]

关键词 LBX2 LBX2-AS1 apoptosis mRNA stability multiple myeloma proliferation

DOI 10.3389/fmolb.2021.706570

PMID 34552959

发布时间 2021-09-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Frontiers in molecular biosciences

2021年8卷

706570页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

LBX2-AS1 as a Novel Diagnostic Biomarker and Therapeutic Target Facilitates Multiple Myeloma Progression by Enhancing mRNA Stability of LBX2.

Frontiers in molecular biosciences

相似文献

Frontiers in molecular biosciences

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

LBX2-AS1 as a Novel Diagnostic Biomarker and Therapeutic Target Facilitates Multiple Myeloma Progression by Enhancing mRNA Stability of LBX2.

Frontiers in molecular biosciences

相似文献

Frontiers in molecular biosciences

相关期刊

检索历史清除